NLR and PLR Levels Following PENG Block in Hip Arthroplasty

NCT07023107 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Hip Arthropathy
Hip Osteoarthritis
Hip Pain Chronic

Interventions

DRUG: 0.9% Sodium Chloride Injection
DRUG: Ropivacaine 0.2% Injectable Solution

Sponsor

Poznan University of Medical Sciences